- Home
- SVRA vs NBN Comparison
SVRA vs NBN Comparison
Compare SVRA & NBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SVRA | NBN |
|---|---|---|
| Founded | 2007 | 1872 |
| Country | United States | United States |
| Employees | N/A | 234 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2009 | N/A |
Fundamental Metrics
Financial Performance| Metric | SVRA | NBN |
|---|---|---|
| Price | $5.05 | $124.70 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 2 |
| Target Price | $10.94 | ★ $143.50 |
| AVG Volume (30 Days) | ★ 1.5M | 90.1K |
| Earning Date | 11-11-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 0.03% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3,963.52 | N/A |
| P/E Ratio | ★ N/A | $11.29 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.34 | $80.75 |
| 52 Week High | $7.01 | $142.31 |
Technical Indicators
Market Signals| Indicator | SVRA | NBN |
|---|---|---|
| Relative Strength Index (RSI) | 45.29 | 34.41 |
| Support Level | $5.16 | $122.41 |
| Resistance Level | $5.49 | $125.64 |
| Average True Range (ATR) | 0.22 | 3.55 |
| MACD | -0.01 | -1.02 |
| Stochastic Oscillator | 45.11 | 3.91 |
Price Performance
Historical ComparisonAbout SVRA Savara Inc.
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).
About NBN Northeast Bank
Northeast Bank provides banking and financial services to individual and corporate customers in the United States. The bank conducts its loan-related activities through two primary channels: the National Lending Division and the Small Business Division. Its loan portfolio comprises residential mortgage loans; multi-family and other commercial real estate loans; commercial and industrial loans; consumer loans; and small business administration loans, among others. Additionally, the bank provides telephone banking, online banking, mobile banking, and remote deposit capture services, and other banking products and services. The majority of its revenue is derived in the form of interest and dividends.